oncological care in Poland: Research

MD Anderson Cancer Center Sister Institution Network Conference:
Research-driven, multidisciplinary
oncological care in Poland:
sharing experiences to foster collaborations
between MD Anderson Cancer Center Sister Institutions
Warszawa, 23–24 czerwca 2014 roku
Warsaw, 23–24 June, 2014
Courtyard by Marriot Airport Hotel, ul. Żwirki i Wigury 1
Courtyard by Marriot Airport Hotel, 1 Zwirki i Wigury Street
PROGRAM/PROGRAMME
www.research.viamedica.pl
PATRONAT HONOROWY/HONORARY PATRONAGE
Ministry of Science
and Higher Education
Republic of Poland
GŁÓWNY PARTNER/MAIN PARTNER:
PARTNERZY/PARTNERS:
Ladies and Gentlemen, Dear Colleagues,
On behalf of the Scientific and Organization Committees, it is our great pleasure and privilege to
welcome you at the conference jointly organized by the Institute of Hematology and Transfusion
Medicine and Maria Sklodowska-Curie Memorial Cancer Center - Institute of Oncology, entitled
“Research-driven, multidisciplinary oncological care in Poland: sharing experiences to
foster collaborations between MD Anderson Cancer Center Sister Institutions”.
During the conference, our American and European partners from the MD Anderson Cancer Center (MDACC) Sister Institution Network will discuss the mission, structure, position in the national
health systems and research activities that their comprehensive cancer centers fulfill in the USA
and Europe. The meeting will also be an excellent opportunity to foster research collaboration
between our institutions. We have invited many distinguished researchers and experts from the
MDACC, Oslo University Hospital (Norway), DKFZ (Germany), Gustave Roussy Institute (France) to
present their latest research findings.
We wish you enjoyable stay in Warsaw,
Krzysztof Warzocha
Przemysław Juszczynski
PROGRAMME — DAY 1, 23rd JUNE
15.30–15.35
Conference opening and welcome address
Krzysztof Warzocha, IHIT, COI, Warsaw
15.35–15.55
A National Institute of Oncology and Hematology project: towards researchdriven and multidisciplinary patient care at a reference institution in Poland
Krzysztof Warzocha, IHiT, COI, Warsaw
15.55–16.05
What is a MDACC Sister Institution network?
Waldemar Priebe, MDACC, Houston
16.05–16.15
Polish institutions in the MDACC SI network — opening new possibilities to foster
collaborations in cancer research
Przemysław Juszczynski, IHiT, Warsaw
16.15–16.35
Comprehensive Cancer Center (CCC) — aims, strategies and activities: the MDACC
experience
Allan McClelland, MDACC, Houston
16.35–16.50
Coffee break
16.50–17.10
Integrating basic, translational and clinical research in a comprehensive cancer
center
Mien-Chie Hung, MDACC, Houston
17.10–17.30
Epidemiology and cancer prevention — a mainstay of a comprehensive cancer
center
Xifeng Wu, MDACC, Houston
17.30–17.50
Comprehensive Cancer Centre in Europe: Norwegian Radium Hospital Experience
Sigbjorn Smeland, Oslo University Hospital
PROGRAMME — DAY 2, 24th JUNE
At the crossroads of basic, translational and clinical research: exchange of experiences and outlooks
for future collaborations:
CONFERENCE ROOM 1
Epidemiology and cancer prevention. Chairs: Witold Zatonski, Ernest Hawk, Xifeng Wu
8.00–8.20
8.20–8.40
8.00–9.30
8.40–8.45
8.45–8.55
8.55–9.05
9.05–9.10
9.10–9.25
Extending the reach of integrative population science: clinical and
population applications — Xifeng Wu (MDACC)
MDACC’s institutional prevention and cancer control programs
— Ernest Hawk (MDACC)
COI institutional cancer epidemiology and prevention programs
— introduction — Witold Zatonski (COI)
Tobacco study — Witold Zatonski (COI)
COI and public education — Marta Manczuk (COI)
National Cancer Registry, integrated system of cancer registration in
Poland — Urszula Wojciechowska (COI)
On the road to improve breast cancer prevention — Jolanta Lissowska (COI)
Discussion
Gastrointestinal tumors. Chairs: Jaroslaw Regula, Lawrence von Karsa
9.30–9.45
9.30–11.00
9.45–10.00
10.00–10.15
10.15–10.30
10.30–11.00
11.00–11.15
Coffee break
Lung cancer. Chairs: Maciej Krzakowski, George Simon
11.15–11.35
11.35–11.45
11.15–12.45
11.45–12.00
12.00–12.15
12.15–12.30
12.45–13.30
15.10–15.20
Clinical significance of epigenetic markers in NSCLC
— George Simon (MDACC)
Targeted therapies for lung cancer patients — current status and
perspectives in Poland — Maciej Krzakowski (COI)
Pathomorphologic approach to the diagnosis of lung cancer in the era
of targeted therapy — Wlodzimerz Olszewski (COI)
Molecular and clinical predictive factors in adequate treatment
selection for lung cancer patients qualification
— Pawel Krawczyk (UM, Lublin)
Lung cancer translational and clinical research collaboration
— perspective of Medical University in Gdansk
— Rafal Dziadziuszko (GUMed)
Discussion
Lunch
Head and neck cancer. Chairs: Boguslaw Maciejewski, Ehab Hanna, Romuald Krajewski
13.30–13.50
13.30–15.10
Developing and implementing European guidelines for colorectal
cancer screening — Lawrence von Karsa (IARC, Lyon)
Comparative effectiveness research and randomized health services
studies — a way to go? — Michael Bretthauer (Oslo University Hospital)
Population based cancer prevention (and screening) studies
— Hermann Brenner (DKFZ, Heidelberg)
CRC screening in Poland — research plans — Michal Kaminski (COI)
Most important unanswered questions in GI cancer prevention — how
to find solutions — roundtable (chairs, all speakers and audience)
Sinonasal cancers: progress, challenges, and future directions
— Ehab Hanna (MDACC)
13.50–14.05 Interdisciplinary head & neck cancer surgery. Looking for an optimal
reconstruction method — Romuald Krajewski, Andrzej Kawecki (COI)
14.05–14.25 Reconstructive surgery for glottic and supraglottic larynx
— Adam Maciejewski (COI — Gliwice)
14.25–14.40 We do not need to extend irradiation on weekends in radiotherapy for
H&N cancer. Results of CAIR-1 and CAIR-2 trials
— Krzysztof Skladowski (COI — Gliwice)
14.40–15.00 Molecularly guided theragnostic radiotherapy
— Boguslaw Maciejewski (COI — Gliwice)
Discussion
Closing of the conference
PROGRAMME — DAY 2, 24th JUNE
At the crossroads of basic, translational and clinical research: exchange of experiences and outlooks
for future collaborations:
CONFERENCE ROOM 2
Breast cancer
Chairs: Maciej Wiznerowicz, Jannik Andersen, Rafał Tarnawski
8.00–8.20
8.20–8.40
8.00–9.30
8.40–9.00
9.00–9.20
The Cancer Genome Atlas: progress and perspectives
— Maciej Wiznerowicz (WCO)
Prediction of response to preoperative breast cancer chemotherapy:
tumor-based markers — Rafał Tarnawski (COI, Gliwice)
Drug target validation and biomarker discovery — Jannik Andersen (MDACC)
Breast cancer brain metastases: differences in survival depending
on biological subtype — Zbigniew Nowecki, Anna Niwinska (COI)
Discussion
Oncohematology
Chairs: Przemyslaw Juszczynski, Richard E. Davis
09.30–09.50
09.50–10.05
09.30–11.00
10.05–10.20
10.20–10.35
10.35–10.50
11.00–11.15
B-cell receptor signaling in lymphoma — Richard E. Davis (MDACC)
FOXO1 is an effector of B-cell receptor pathway inhibition DLBCL
— Przemyslaw Juszczynski (IHT)
Translational studies and phase I trials at Institute Gustave Roussy
— Vincent Ribrag (Institut Gustave Roussy)
Novel translational insights from studies of myeloma biology
— Robert Orlowski (MDACC)
Therapeutic approaches to transcriptional control of cancer
— Waldemar Priebe (MDACC)
Discussion
Coffee break
Soft tissue sarcomas/melanoma
Chairs: Piotr Rutkowski, Shreyaskumar R. Patel
11.15–11.40
11.15–12.45
11.40–12.05
12.05–12.30
12.45–13.30
Achievements of Polish Clinical GIST Registry. Possible fields
for collaboration in rare sarcomas — Piotr Rutkowski (COI)
Systemic therapy for STS – how to personalize in 2014?
— Shreyaskumar R. Patel (MDACC)
Advances in molecular pathogenesis of cutaneous and unknown
primary melanoma — Tomasz Switaj (COI)
Discussion
Lunch
13.30–15.10
15.10–15.20
Closing of the conference
Small conference rooms are available for session chairs and invited guests for discussions
INFORMACJE OGÓLNE/GENERAL INFORMATION
KONTAKT/CONTACT DETAILS
VM Media sp. z o.o. VM Group sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.: (58) 320 94 94, faks: (58) 320 94 60, e-mail: [email protected]
PUNKTY EDUKACYJNE/EDUCATIONAL CREDITS
Uprzejmie informujemy, że za udział w konferencji zostanie przyznanych 8 punktów edukacyjnych.
8 educational credits will be awarded for participation in the conference.
CERTYFIKATY UCZESTNICTWA/CERTIFICATES OF PARTICIPATION IN CONFERENCE
Informujemy, że certyfikaty będą wydawane jedynie za okazaniem identyfikatora.
The certificates will be issued only upon presentation of the badge.
Konferencja skierowana jest do osób uprawnionych do wystawiania recept lub osób prowadzących obrót produktami leczniczymi
— podstawa prawna Ustawa z dnia 6 września 2001 r. Prawo farmaceutyczne (Dz.U. z 2008 r. nr 45, poz. 271).
The conference is addressed to individuals authorised to issue medical prescriptions or individuals marketing medicinal products.
Legal basis: Act of 6 September 2001 “The Pharmaceutical Law” (Journal of Laws of 2008, no 45, item 271).